Bain Capital Life Sciences Investors, LLC
Top Portfolio Positions
18 positions ·
$1,101,227,906 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| HTFL |
Heartflow, Inc.
Healthcare
|
10,448,158 | $254,203,684 | 23.08% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
7,306,566 | $233,883,177 | 21.24% | |
| OLMA |
Olema Pharmaceuticals, Inc.
Healthcare
|
7,473,238 | $111,425,978 | 10.12% | |
| SVRA |
Savara Inc
Healthcare
|
17,600,621 | $96,099,390 | 8.73% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
2,675,509 | $75,583,129 | 6.86% | |
| SLDB |
Solid Biosciences Inc.
Healthcare
|
9,808,819 | $70,623,496 | 6.41% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
7,967,454 | $32,905,585 | 2.99% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
362,470 | $30,418,482 | 2.76% | |
| ANNX |
Annexon, Inc.
Healthcare
|
5,212,674 | $28,878,213 | 2.62% | |
| KYTX |
Kyverna Therapeutics, Inc.
Healthcare
|
3,110,000 | $26,839,300 | 2.44% |
Portfolio Trend
25 quarters · across all stocks
Holdings in OLMA
Shares Held
Position Value (USD)
6 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $111,425,978 | 7,473,238 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $212,716,025 | 8,508,641 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $67,002,309 | 6,843,954 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $29,155,244 | 6,843,954 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $25,733,267 | 6,843,954 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $43,551,347 | 7,470,214 | Shares | Sole | 2025-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||